Label: RICE FOOD- oryza sativa solution
RYE FOOD- secale cereale solution
SESAME SEED- sesamum indicum solution
BROCCOLI- brassica oleracea var. botrytis solution
BUCKWHEAT- fagopyrum esculentum solution
CASHEW NUT- anacardium occidentale solution
CAULIFLOWER- brassica oleracea var. botrytis solution
CHOCOLATE CACAO BEAN- theobroma cacao solution
CANTALOUPE MUSKMELON- cucumis melo solution
CARROT- daucus carota solution
CELERY- apium graveolens var. dulce solution
LETTUCE- lactuca sativa solution
FILBERT HAZELNUT FOOD- corylus americana solution
VANILLA- vanilla planifolia solution
WHOLE WHEAT- triticum aestivum solution
APRICOT- prunus armeniaca solution
WHOLE GRAIN BARLEY- hordeum vulgare solution
NAVY BEAN- phaseolus vulgaris solution
STRING GREEN BEAN- phaseolus vulgaris solution
CABBAGE- brassica oleracea var. capitata solution
CINNAMON- cinnamomum verum solution
COFFEE- coffea arabica solution
MUSHROOM- agaricus campestris solution
MUSTARD FOOD- sinapis alba solution
BANANA- musa acuminata solution
COCONUT- cocos nucifera solution
CORN FOOD- zea mays solution
MALT- hordeum vulgare solution
BLACK PEPPER- piper nigrum solution
LEMON- citrus x limon solution
OAT FOOD- avena sativa solution
ONION- allium cepa solution
CUCUMBER- cucumis sativus solution
BLUEBERRY- vaccinium myrtilloides solution
GINGER- zingiber officinale solution
WHITE SEEDLESS GRAPE- vitis vinifera solution
TOMATO- solanum lycopersicum solution
GARLIC- allium sativum solution
SOYBEAN FOOD- glycine max solution
SPINACH- spinacia oleracea solution
GREEN PEPPER- piper nigrum solution
PINEAPPLE- ananas comosus solution
STRAWBERRY- fragaria x ananassa solution
YELLOW SUMMER SQUASH- cucurbita pepo var. ovifera solution
BRAZIL NUT- bertholletia excelsa solution
CRANBERRY- vaccinium macrocarpon solution
GREEN OLIVE- olea europaea solution
CHERRY- prunus avium solution
LIMA BEAN- phaseolus lunatus solution
HOPS FOOD- humulus lupulus solution
NUTMEG- myristica fragrans solution
PECAN FOOD- carya illinoinensis solution
SWEET POTATO- ipomoea batatas solution
WHITE POTATO- solanum tuberosum solution
RED RASPBERRY- rubus idaeus solution
ORANGE- citrus x sinensis solution
BLACK WALNUT FOOD- juglans nigra solution
WATERMELON- citrullus lanatus solution
GRAPEFRUIT- citrus x paradisi solution
PEACH- prunus persica solution
PEANUT- arachis hypogaea solution
GREEN ENGLISH PEA- pisum sativum solution
PEAR- pyrus communis solution
BEEF- bos taurus solution
CHICKEN MEAT- gallus gallus solution
CHICKEN EGG WHITE- gallus gallus solution
CHICKEN EGG YOLK- gallus gallus solution
CHICKEN EGG WHOLE- gallus gallus solution
LAMB- ovis aries solution
PORK- sus scrofa solution
TURKEY MEAT- meleagris gallopavo solution
COW MILK- bos taurus solution
BLACK BASS- centropristis striata solution
CATFISH- ictalurus punctatus solution
CLAM- mercenaria mercenaria solution
ATLANTIC COD- gadus morhua solution
CRAB- callinectes sapidus solution
FISH MIX- gadus morhua, paralichthys lethostigma, hippoglossus hippoglossus, scomber scombrus and thunnus albacares solution
SHELLFISH MIX- mercenaria mercenaria, callinectes sapidus, crassostrea virginica, placopecten magellanicus and farfantepenaeus aztecus solution
FLOUNDER- paralichthys lethostigma solution
MAINE LOBSTER- homarus americanus solution
MACKEREL- scomber scombrus solution
OYSTER- crassostrea virginica solution
OCEAN PERCH- sebastes alutus solution
SALMON- salmo salar solution
SCALLOPS- placopecten magellanicus solution
SHRIMP- farfantepenaeus aztecus solution
LAKE TROUT- oncorhynchus mykiss solution
TUNA- thunnus albacares solution
ALMOND FOOD- prunus dulcis solution
APPLE- malus pumila solution
ENGLISH WALNUT- juglans regia solution

  • NDC Code(s): 22840-5700-2, 22840-5700-5, 22840-5701-2, 22840-5701-5, view more
    22840-5702-2, 22840-5702-5, 22840-5703-2, 22840-5703-5, 22840-5704-2, 22840-5704-5, 22840-5705-2, 22840-5705-5, 22840-5706-2, 22840-5706-5, 22840-5707-2, 22840-5707-5, 22840-5708-2, 22840-5708-5, 22840-5709-2, 22840-5709-5, 22840-5710-2, 22840-5710-5, 22840-5711-2, 22840-5711-5, 22840-5712-2, 22840-5712-5, 22840-5713-2, 22840-5713-5, 22840-5714-2, 22840-5714-5, 22840-5715-2, 22840-5715-5, 22840-5716-2, 22840-5716-5, 22840-5717-2, 22840-5717-5, 22840-5718-2, 22840-5718-5, 22840-5719-2, 22840-5719-5, 22840-5720-2, 22840-5720-5, 22840-5721-2, 22840-5721-5, 22840-5722-2, 22840-5722-5, 22840-5723-2, 22840-5723-5, 22840-5724-2, 22840-5724-5, 22840-5725-2, 22840-5725-5, 22840-5726-2, 22840-5726-5, 22840-5727-2, 22840-5727-5, 22840-5728-2, 22840-5728-5, 22840-5729-2, 22840-5729-5, 22840-5730-2, 22840-5730-5, 22840-5731-2, 22840-5731-5, 22840-5732-2, 22840-5732-5, 22840-5733-2, 22840-5733-5, 22840-5734-2, 22840-5734-5, 22840-5735-2, 22840-5735-5, 22840-5736-2, 22840-5736-5, 22840-5737-2, 22840-5737-5, 22840-5738-2, 22840-5738-5, 22840-5739-2, 22840-5739-5, 22840-5740-2, 22840-5740-5, 22840-5741-2, 22840-5741-5, 22840-5742-2, 22840-5742-5, 22840-5743-2, 22840-5743-5, 22840-5744-2, 22840-5744-5, 22840-5745-2, 22840-5745-5, 22840-5746-2, 22840-5746-5, 22840-5747-2, 22840-5747-5, 22840-5748-2, 22840-5748-5, 22840-5749-2, 22840-5749-5, 22840-5750-2, 22840-5750-5, 22840-5751-2, 22840-5751-5, 22840-5752-2, 22840-5752-5, 22840-5753-2, 22840-5753-5, 22840-5754-2, 22840-5754-5, 22840-5755-2, 22840-5755-5, 22840-5756-2, 22840-5756-5, 22840-5757-2, 22840-5757-5, 22840-5758-2, 22840-5758-5, 22840-5759-2, 22840-5759-5, 22840-5760-2, 22840-5760-5, 22840-5761-2, 22840-5761-5, 22840-5762-2, 22840-5762-5, 22840-5763-2, 22840-5763-5, 22840-5764-2, 22840-5764-5, 22840-5765-2, 22840-5765-5, 22840-5766-2, 22840-5766-5, 22840-5767-2, 22840-5767-5, 22840-5768-2, 22840-5768-5, 22840-5769-2, 22840-5769-5, 22840-5770-2, 22840-5770-5, 22840-5771-2, 22840-5771-5, 22840-5772-2, 22840-5772-5, 22840-5773-2, 22840-5773-5, 22840-5774-2, 22840-5774-5, 22840-5775-2, 22840-5775-5, 22840-5776-2, 22840-5776-5, 22840-5777-2, 22840-5777-5, 22840-5778-2, 22840-5778-5, 22840-5779-2, 22840-5779-5, 22840-5780-2, 22840-5780-5, 22840-5781-2, 22840-5781-5, 22840-5782-2, 22840-5782-5, 22840-5783-2, 22840-5783-5, 22840-5784-2, 22840-5784-5, 22840-5785-2, 22840-5785-5, 22840-5786-2, 22840-5786-4, 22840-5786-5, 22840-5787-2, 22840-5787-5, 22840-5788-2, 22840-5788-5, 22840-5789-2, 22840-5789-5, 22840-9700-2, 22840-9700-5, 22840-9701-2, 22840-9701-5
  • Packager: Greer Laboratories, Inc.
  • Category: NON-STANDARDIZED ALLERGENIC LABEL
  • DEA Schedule: None
  • Marketing Status: Biologic Licensing Application

Drug Label Information

Updated November 9, 2018

If you are a consumer or patient please visit this version.

  • BOXED WARNING(What is this?)

    WARNING

    THIS ALLERGENIC PRODUCT IS INTENDED FOR USE BY PHYSICIANS WHO ARE EXPERIENCED IN THE ADMINISTRATION OF ALLERGENIC EXTRACTS AND THE EMERGENCY CARE OF ANAPHYLAXIS, OR FOR USE UNDER THE GUIDANCE OF AN ALLERGY SPECIALIST.

    ALLERGENIC EXTRACTS MAY CAUSE SEVERE OR FATAL ANAPHYLAXIS IN EXTREMELY SENSITIVE PATIENTS. THE INITIAL DOSE MUST BE BASED ON SKIN TESTING AS DESCRIBED IN THE DOSAGE AND ADMINISTRATION SECTION OF THIS INSERT. PATIENTS SHOULD BE INSTRUCTED TO RECOGNIZE ADVERSE REACTION SYMPTOMS AND CAUTIONED TO CONTACT THE PHYSICIAN'S OFFICE IF REACTION SYMPTOMS OCCUR. IN CERTAIN INDIVIDUALS, THESE REACTIONS COULD BE FATAL. PATIENTS SHOULD BE OBSERVED FOR AT LEAST 20 MINUTES FOLLOWING TREATMENT.

    EMERGENCY MEASURES, AS WELL AS PERSONNEL TRAINED IN THEIR USE, SHOULD BE IMMEDIATELY AVAILABLE IN THE EVENT OF A LIFE‑ THREATENING REACTION. PATIENTS BEING SWITCHED FROM ONE LOT OF EXTRACT TO ANOTHER FROM THE SAME MANUFACTURER SHOULD HAVE THEIR DOSE REDUCED BY 75%.

    THIS PRODUCT SHOULD NOT BE INJECTED INTRAVENOUSLY.

    REFER ALSO TO THE WARNINGS, PRECAUTIONS, ADVERSE REACTIONS AND OVERDOSAGE SECTION BELOW.

    Close
  • DESCRIPTION

    Allergenic Extracts are supplied as a sterile solution for intracutaneous or subcutaneous administration. Concentrates contain the soluble extractants of the source material with 0.5% sodium chloride and 0.54% sodium bicarbonate at a pH of 6.8 to 8.4 as aqueous extracts in water for injection or in 50% glycerin. Aqueous extracts contain 0.4% phenol as a preservative and 50% glycerinated extracts contain 0.2% phenol. Diluted aqueous extracts contain Buffered Saline with 0.5% sodium chloride, 0.04% potassium phosphate, 0.11% sodium phosphate heptahydrate, and 0.4% phenol in water for injection.

    Source materials for these extracts are as follows: Pollens are collected from the respective grasses, weeds, trees, shrubs, cultured plants and flowers. Mold extracts are produced from pure culture mycelial mats. Rusts and smuts are obtained from natural growths. Epidermal extracts are produced from the hide, hair, or feathers containing the natural dander, or from separated dander. Insects are the whole body insects. House dust is made from various dusts ordinarily found in the home with the extract dialyzed to remove low‑molecular weight irritants and concentrated to an extraction ratio of 1:1. Food extracts are prepared from the edible portions of the respective foods, obtained fresh if possible. Certain diagnostic food extracts contain 0.1% sodium formaldehyde sulfoxylate as an antioxidant. Other miscellaneous inhalants involved in respiratory allergy are obtained in the naturally occurring form to which a patient may be exposed.

    Extracts are labeled either by weight‑to‑volume (w/v) based on the weight of the source material to the volume of the extracting fluid, or in protein nitrogen units (PNU) based on assay with one PNU representing 0.00001 mg of protein nitrogen.

    Close
  • CLINICAL PHARMACOLOGY

    The allergic reaction is dependent upon the presence of antigen‑specific immunoglobulin E (IgE) antibodies that are bound to specific receptors on mast cells and basophils. The presence of IgE antibodies on mast cells and basophils sensitizes these cells and, upon interaction with the appropriate allergen, histamine and other mediators are released. IgE antibody has been shown to correlate with atopic diseases such as allergic rhinitis and allergic asthma. (1‑4) In the skin these mediators are responsible for the characteristic wheal and flare (erythema) reactions upon Allergenic Extract skin testing in persons with the specific allergies. (3‑7)

    Specific immunotherapy with Allergenic Extracts as employed for over 45 years is helpful in reducing symptoms associated with exposure to the offending allergens. A summary of effectiveness by the Panel on Review of Allergenic Extracts, an advisory committee to the U.S. Food and Drug Administration, has been published. (8) Several mechanisms have been proposed to explain the effectiveness of immunotherapy: an increase in antigen‑specific IgG antibodies is frequently associated with clinical effectiveness, although correlation is not consistent in all studies; there is a decrease in specific IgE; and IgE production is suppressed during periods of seasonal or high exposure to the antigen. (9) Other changes following immunotherapy have been noted including development of auto‑anti‑idiotypic antibodies; a decrease in blood basophil sensitivity to allergen; a decrease in lymphokine production and lymphocyte proliferation by cells exposed to allergen; and development of allergen‑specific suppressor cells. (10) The complete mechanisms of immunotherapy are not known and remain the subject of investigation.

    Close
  • INDICATIONS & USAGE

    Allergenic Extracts are indicated for the diagnosis and treatment of patients with immediate hypersensitivity allergy to the respective allergens, inhaled, ingested or otherwise introduced into contact with sensitive tissues. The diagnosis of IgE‑mediated allergy may be established by the allergy history, clinical evaluation, and skin test reactivity. (4,7,11) Immunotherapy with Allergenic Extracts is indicated when testing and patient history have identified the offending allergens and when it is not possible or practical to avoid these allergens. (12‑14) Food extracts have not been proven effective in immunotherapy.

    The use of Allergenic Extracts for the above purposes should be made only by physicians with special familiarity and knowledge of allergy. (See DOSAGE AND ADMINISTRATION)

    Close
  • CONTRAINDICATIONS

    There are no known absolute contraindications to the use of Allergenic Extracts for immunotherapy. Immunotherapy with specific antigens should not be done in those individuals who do not exhibit skin test or clinical sensitivity to the particular antigens. (See below under WARNINGS and PRECAUTIONS)

    Allergenic extract injections should not be administered in the presence of diseases characterized by a bleeding diathesis.

    Children with nephrotic syndrome require careful consideration and probably should not receive injection therapy because a variety of seemingly unrelated events, such as immunization, can cause an exacerbation of their nephrotic disease.

    General contraindications include:

    EXTREME SENSITIVITY TO THE SPECIFIC ALLERGEN ‑ Determined from previous anaphylaxis following exposure.

    AUTOIMMUNE DISEASE ‑ Individuals with autoimmune disease may be at risk, due to the possibility of routine immunizations exacerbating symptoms of the underlying disease.

    Close
  • WARNINGS

    Concentrated extracts must be diluted with a sterile diluent prior to first use on a patient for treatment or intradermal testing. Allergenic Extracts are manufactured to assure high potency and have the ability during skin testing and immunotherapy to cause serious local and systemic reactions including death in sensitive patients. Most reactions occur within 20 minutes after injection, (15) but may occur later. (16) To minimize the potential for local or systemic reactions, the relative sensitivity of the patient must be assessed from the allergic history and from clinical observations. Patients should be informed of these risks prior to skin testing and immunotherapy (see PRECAUTIONS and ADVERSE REACTIONS below).

    Allergenic Extract immunotherapy doses should be lowered or temporarily withheld from patients if any of the following conditions exist:

    (1) severe symptoms of rhinitis and/or asthma

    (2) infection or flu accompanied by fever

    (3) exposure to excessive amounts of clinically relevant allergen prior to a scheduled injection

    (4) evidence of a local or systemic reaction to the preceding extract injection during a course of immunotherapy

    The dosage must be reduced when modifying dosages or components in a mixture or an individual prescription, or when starting a patient on fresh extract, even though the labeled strength of the old and new vials may be the same. This reduction in dosage may be necessary due to the older vial losing potency during storage, or due to different sensitivities to different components. The amount of new extract given should not exceed 25% of the last dose given from the old vial, assuming both extracts contain comparable amounts of allergen. Any evidence of a local or generalized reaction requires a reduction in dosage during the initial stages of immunotherapy, as well as during maintenance therapy.

    Close
  • PRECAUTIONS

    GENERAL:

    Not for intravenous use!

    Systemic allergic reactions may occur as a result of immunotherapy. The risk can be minimized by adherence to a careful injection schedule, which starts with a low concentration of extract and is increased slowly. Because of the danger of serious reactions, caution is needed in testing exquisitely sensitive patients, particularly with potent allergens, e.g., peanut, cottonseed, and flaxseed. (8) Such extracts should be appropriately diluted before use.

    The physician must be prepared to treat anaphylaxis should it occur and have the necessary drugs and equipment on hand to do so. (17‑18) Extracts should not be administered by the patient or other individuals who are not prepared to treat anaphylaxis should it occur.

    Patients receiving Allergenic Extracts should be kept under observation a minimum of twenty (20) minutes so that any adverse reaction can be observed and properly handled. (15) This time should be extended for high‑risk patients such as those with unstable asthma or those suffering an exacerbation of their symptoms.

    Patients receiving beta blockers may not be responsive to beta adrenergic drugs used to treat anaphylaxis. The risks of anaphylaxis in these patients should be carefully weighed against the benefits of immunotherapy.

    Check the lot number and dosage schedule of the patient to verify correctness of a prescription number, a vial number, or strength. Only after this verification has been made should an injection be given.

    A separate sterile needle and syringe should be used for each patient to prevent transmission of hepatitis or other infectious agents.

    INFORMATION FOR PATIENTS:

    Most serious reactions following the administration of Allergenic Extracts occur within 20 minutes; the patient should remain under observation for this period of time or longer if instructed by the physician. The size of any local reaction should be recorded, because increasingly large local reactions may precede a subsequent systemic reaction with increasing dosage. The patient should be instructed to report any unusual reactions. In particular, this includes unusual swelling and/or tenderness at the injection site, or reactions such as rhinorrhea, sneezing, coughing, wheezing, shortness of breath, nausea, dizziness, or faintness. Reactions may occur some time after leaving the physician's office, in which case medical attention should be sought immediately.

    DRUG INTERACTIONS: Skin test diagnosis with Allergenic Extracts is contraindicated within 24 hours after the last dose of most antihistamines, within 48 hours after the last dose of terfenadine, and within 3 weeks or longer after the last dose of astemizole. These products suppress histamine skin test reactions and could mask a positive response.

    CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY: There is no evidence of carcinogenicity, mutagenesis or impairment of fertility in humans from Allergenic Extracts. No long‑term studies in animals have been performed to evaluate carcinogenic potential.

    PREGNANCY: PREGNANCY CATEGORY C ‑ Animal reproduction studies have not been conducted with Allergenic Extracts. It is also not known whether Allergenic Extracts can cause fetal harm when administered to a pregnant woman or whether they can affect reproduction capacity. Allergenic Extracts should be given to a pregnant woman only if clearly needed.

    There is no evidence of adverse effects of Allergenic Extracts on the fetus. (8) Studies have not been performed in animals to determine whether extracts affect fertility in males or females, have teratogenic potential, or have other adverse effects on the fetus. Caution should be exercised in testing or treating pregnant females because a systemic reaction may cause an abortion as a result of uterine muscle contractions.

    LABOR AND DELIVERY: There is no known information of adverse effects during labor and delivery.

    NURSING MOTHERS: It is not known whether this product is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when extracts are administered to a nursing woman.

    PEDIATRIC AND GERIATRIC USE: Although most extracts have not been studied systematically in children, children and geriatric patients appear to tolerate injections of Allergenic Extracts well. Studies with pollenosis and asthma have been conducted in children (e.g. refs. 19‑21). Extract usage in children should follow the same precautions as in adults.

    Close
  • ADVERSE REACTIONS

    Adverse systemic reactions may occur within minutes upon use of an Allergenic Extract to which a person has specific sensitivity. These reactions consist primarily of allergic symptoms such as generalized skin erythema, urticaria, pruritus, angioedema, rhinitis, wheezing, laryngeal edema, and hypotension. Less commonly, nausea, emesis, abdominal cramps, diarrhea and uterine contractions may occur. Severe reactions may cause shock and loss of consciousness. Fatalities have occurred rarely. (8,22,23) These systemic reactions occur with varying frequency in different clinics and are usually less than 1%. To some extent, the reaction rate is related to the type and dose of administered extract and to the sensitivity of the patient. In general, immunotherapy with Allergenic Extracts is considered to be safe. (24) Despite all precautions, occasional reactions are unavoidable.

    Adverse systemic reactions should be treated as follows:

    A. A tourniquet should be immediately applied to the extremity above the site of injection. Release the tourniquet every few minutes for a few seconds.

    B. Epinephrine 1:1000 should be injected immediately in the opposite arm in amounts of 0.3 to 0.5 mL and 0.2 mL epinephrine should be administered at the site of injection. For children below the age of 6 years, adjust the dosage of epinephrine to 0.005 mL per pound of body weight per dose. Repeat epinephrine dosage in 15 minutes if necessary and if symptoms persist.

    C. Adverse reactions not responding to epinephrine therapy may require the use of parenteral bronchodilators, vasopressors, oxygen, or volume replacement therapy.

    Local reactions consisting of erythema, itching, swelling, tenderness and sometimes pain may occur at the injection site. These reactions may appear within a few minutes to hours and persist for several days. Local cold applications and oral antihistamines may be effective treatment. For marked and prolonged local reactions, steroids may be helpful.

    Close
  • OVERDOSAGE

    Systemic reactions are uncommon after injection, but if the patient receives more extract than can be tolerated at that particular time and begins to experience immediate hypersensitivity anaphylaxis, the procedures listed under ADVERSE REACTIONS should be instituted.

    Overdosage may occur because of an error in the volume of extract injected, or an incorrect dilution injected, or because the patient may be exposed to airborne or environmental antigens simultaneously with injection of the same antigens. In the event of a systemic reaction occurring, the dosage schedule should be carefully adjusted as outlined above under WARNINGS.

    Close
  • DOSAGE & ADMINISTRATION

    1. DIAGNOSTIC TESTING

    For the patient with a suspected diagnosis of allergy to more than one antigen, initial skin testing should include the individual extracts. If a screening skin test with a mixture is used, a positive response should be followed by testing with the individual extracts to determine the degree of sensitivity to each and to guide in the selection of extracts and their concentration for immunotherapy if indicated. However, because a negative skin test with a mixture may not be indicative of the absence of allergy to one or more of the components due to their dilution, testing with individual extracts is more precise. False negative responses may occur if serum levels of antihistamines remain from prior medication administration (see CONTRAINDICATIONS). The use of a positive control is especially recommended for patients on prior medications which may decrease the histamine skin test response.

    Scratch or Prick‑puncture Skin Testing:

    Allergenic Extract concentrates may be used for scratch or prick‑puncture testing or scratch tests in 50% glycerin, 1:20 w/v or strongest available strength in 5 mL vials may be used. Prick‑puncture tests with concentrated extracts in patients highly sensitive to the specific antigen should yield distinctive wheals with diameters of greater than 5 mm and with much larger erythema reactions. Glycerinated histamine phosphate 5 mg/mL (1.8 mg/mL histamine base) or aqueous histamine phosphate 2.75 mg/mL (1 mg/mL histamine base; 1:1,000 W/V) may be used as a positive control.

    Intradermal Skin Testing:

    Extract for intradermal testing must be prepared by diluting the stock concentrate injection vials with sterile diluent (use normal or buffered saline, or normal saline with human serum albumin) or the appropriate dilutions may be purchased.

    a. Patients with a negative scratch or prick‑puncture test:

    Patients who do not react to a scratch or prick‑puncture test should be tested intradermally, using a 26 or 27 gauge 1/4 inch needle, with 0.02 to 0.05 mL of an appropriate extract dilution from 1/100 to 1/1000 of the concentrate. A negative test should be followed by a repeat test using a higher concentration until significant wheal and flare reaction sizes are attained or until the responses remain negative. As a negative control use the diluent or, in the case of extracts in 50% glycerin, use 0.5% to 1% glycerosaline solution. As a positive control, use glycerinated histamine phosphate diluted to 0.5 mg/mL (0.18 mg/mL histamine base) or aqueous histamine phosphate 0.275 mg/mL (0.1 mg/mL histamine base).

    b. Patients tested only by the intradermal method:

    Since highly reactive individuals may react intracutaneously at 1:1 million or even 1:10 million dilutions, any intradermal injection should be preceded by a puncture test and the dose adjusted accordingly. Other patients suspected of being moderately allergic should be tested with 0.02 to 0.05 mL of an appropriate extract dilution on the order of 1/10,000 to 1/100,000 of the concentrate. A negative test should be followed by repeat tests using progressively stronger ten‑fold concentrations until significant wheal and flare reaction sizes are attained, or until skin test responses with the higher concentrations remain negative. As a negative control, use the diluent or, in the case of extracts in 50% glycerin, use 0.5% to 1% glycerosaline solution. As a positive control, use glycerinated histamine phosphate diluted to 0.5 mg/mL (0.18 mg/mL histamine base) or aqueous histamine phosphate 0.275 mg/mL (0.1 mg/mL histamine base).

    Skin tests are graded in terms of the wheal and erythema response noted at 15 to 20 minutes, and compared to the appropriate controls. Wheal and erythema sizes may be recorded by actual measurement.

    2. IMMUNOTHERAPY

    Immunotherapy is administered by subcutaneous injection. Dosage of Allergenic Extracts is individualized according to the patient's sensitivity, the clinical response, and tolerance to the extract administered during the phases of an injection regimen. The initial dose of the extract should be determined based on the puncture test reactivity. In patients who appear to be exquisitely sensitive by history and skin test, the initial dose of the extract should be 0.05 to 0.1 mL of a low concentration, such as dilution number 5 or 6 in below. Patients with lesser sensitivity may be started with 0.05 to 0.1 mL of the next higher concentration. The amount of Allergenic Extract is increased at each injection by no more than 50% of the previous amount, and the next increment is governed by the response to the last injection. Large local reactions which persist for longer than 24 hours are generally considered an indication for repeating the previous dose or reducing the dose at the next administration. Any evidence of systemic reaction is an indication for a reduction of 75% in the subsequent dose. The upper limits of dosage have not been established; however, doses larger than 0.2 mL of an extract in 50% glycerin may cause discomfort upon injection. The dosage of Allergenic Extract does not vary significantly with the allergic disease under treatment.

    To prepare dilutions starting from a concentrate such as 1:10 W/V, 1:20 W/V, OR 20,000 PNU/mL, proceed as in Table 1 below. (Note: Add 0.5 mL of concentrate to 4.5 mL of sterile diluent and make additional dilutions in the same manner.)

    TABLE 1

    Ten-Fold Dilution Series *
    *
    There is no direct potency correlation across the table between PNUs and W/V.
    Dilution Extract Diluent W/V W/V PNU/mL
    0 Concentrate 1:10 1:20 20,000
    1 0.5 mL in dilution concentrate 4.5 mL

    1:100

    1:200 2,000
    2 0.5 mL in dilution 1 4.5 mL 1:1,000 1:2,000 200
    3 0.5 mL in dilution 2 4.5 mL 1:10,000 1:20,000 20
    4 0.5 mL in dilution 3 4.5 mL 1:100,000 1:200,000 2
    5 0.5 mL in dilution 4 4.5 mL 1:1,000,000 1:2,000,000 0.2
    6 0.5 mL in dilution 5 4.5 mL 1:10,000,000 1:20,000,000 0.0

    Close
  • HOW SUPPLIED

    Stock concentrate extracts containing up to 40,000 PNU/mL, or 1:10 W/V or other dilutions as requested by the physician are supplied in 5, 10, 30 and 50 mL in aqueous or 50% glycerin buffered saline. House dust extract is supplied in a 1:1 W/V concentrate, or a maximum of 10,000 PNU/mL. Extracts are also supplied in dropper vials for scratch or prick testing.

    Close
  • STORAGE AND HANDLING

    Allergenic Extracts should be stored at 2‑8°C and kept at this temperature range during office use. Refer to vial labels for expiration dates. Diluted extracts are inherently less stable than concentrates. Dilutions of glycerinated extracts which result in glycerin below 50% are also less stable. The more dilute extracts in aqueous diluents should be replenished daily. Potency of a particular dilution can be checked by skin test in comparison to a fresh dilution of the extract on an individual known to be allergic to the specific antigen.

    Close
  • REFERENCES

    1. Lichtenstein LM, Ishizaka K, Norman PS, et al. IgE antibody measurements in ragweed hayfever: relationship to clinical severity and the results of immunotherapy. J Clin Invest 1973;52:474.
    2. Elgefors B, Julin A, Johansson SGO. Immunoglobulin E in bronchial asthma. Acta Allergol 1974;29:327.
    3. Norman PS. The clinical significance of IgE. Hosp Pract 1975;10:41‑49.
    4. Bryant DA, Burns MW, Lazarus L. The correlation between skin tests, bronchial provocation tests and the serum level of IgE specific for common allergens in patients with asthma. Clin Allergy 1975;5:145.
    5. Loeffler JA, Cawley LP, Moeder M. Serum IgE levels: correlation with skin test sensitivity. Ann Allergy 1973;31:331.
    6. Pepys J. Skin tests in diagnosis. In Gell PGH, Coombs RRA, Lachman PJ, eds. Clinical aspects of Immunology. Oxford: Blackwell Scientific Publications, 1975.
    7. Burrows B, et al. Respiratory disorders and allergy skin test reactions. Ann Allergy 1976;84:134.
    8. Implementation of Efficacy Review, Allergenic Extracts. Federal Register 1985;50:3082‑3288
    9. Levy DA, Lichenstein LM, Goldstein EO, Ishizaka K. Immunologic and cellular changes accompanying the therapy of pollen allergy. J Clin Invest 1973;50:360.
    10. Gurka G, Rocklin R. Immunologic responses during allergen-specific immunotherapy for respiratory allergy. Ann Allergy 1988;61:239-43.
    11. Zeiss CR Jr. Patient evaluation. In: Allergy and Clinical Immunology, Locky RF, ed. Garden City, N.Y.: Medical Examination Publishing 1976:616.
    12. Frankland AW, Augustin R. Prophylaxis of summer hay‑fever and asthma: a controlled trial comparing crude grass‑pollen extracts with the isolated main protein component. Lancet 1954;1:1055.
    13. Frankland AW, Augustin R. Grass pollen antigens effective in treatment. Clin Sci 1962;23:95.
    14. Rohr AS, Marshall NA, Saxon A: Successful immunotherapy for Triatoma protracta‑induced anaphylaxis. J Allergy Clin Immunol 1984;73:369‑75.
    15. Executive Committee, American Academy of Allergy and Immunology. The waiting period after allergen skin testing and immunotherapy (Position statement). J Allergy Clin Immunol 1990;85:526‑7.
    16. Greenberg MA, Kaufman CR, Gonzalez GE, Rosenblatt CD, Smith LJ, Summers RJ. Late and immediate systemic‑allergic reactions to inhalant allergen immunotherapy. J Allergy Clin Immunol 1986;77:865‑70.
    17. Ouellette JJ. Emergency management of the allergic reactions. Modern Medicine 1975;99.
    18. Anderson JA, et al. Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts. J Allergy Clin Immunol 1986;77:271‑3.
    19. Sadan N, Rhyne MB, Mellits ED, et al. Immunotherapy of pollenosis in children: investigation of the immunologic basis of clinical improvement. N Eng J Med 1969;280:623.
    20. Johnstone DE. Value of hyposensitization therapy for perennial bronchial asthma in children. Pediatrics 1961;27:39.
    21. VanAsperin PP, Kemp AS, Mellis CM. Skin test reactivity and clinical allergen sensitivity in infancy. J Allergy Clin Immunol 1984;73:381‑6.
    22. Committee on Safety of Medicine. Desensitizing vaccines. Br Med J 1986;293:948.
    23. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987;79:660‑77.
    24. Norman PS, Van Metre TE Jr. The safety of allergenic immunotherapy. J Allergy Clin Immunol 1990;85:522‑5.
    Close
  • INGREDIENTS AND APPEARANCE
    RICE FOOD 
    oryza sativa solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5746
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BROWN RICE (UNII: 659G217HPG) (BROWN RICE - UNII:659G217HPG) BROWN RICE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5746-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5746-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    RYE FOOD 
    secale cereale solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5747
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RYE (UNII: 0R4AQI398X) (RYE - UNII:0R4AQI398X) RYE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5747-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5747-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    SESAME SEED 
    sesamum indicum solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5748
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SESAME SEED (UNII: 7Y1255HVXR) (SESAME SEED - UNII:7Y1255HVXR) SESAME SEED 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5748-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5748-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    BROCCOLI 
    brassica oleracea var. botrytis solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5708
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BROCCOLI (UNII: UOI4FT57BZ) (BROCCOLI - UNII:UOI4FT57BZ) BROCCOLI 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5708-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5708-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    BUCKWHEAT 
    fagopyrum esculentum solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5709
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BUCKWHEAT (UNII: N0Y68724R3) (BUCKWHEAT - UNII:N0Y68724R3) BUCKWHEAT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5709-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5709-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CASHEW NUT 
    anacardium occidentale solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5783
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ANACARDIUM OCCIDENTALE FRUIT (UNII: 4A10JR4E7E) (ANACARDIUM OCCIDENTALE FRUIT - UNII:4A10JR4E7E) ANACARDIUM OCCIDENTALE FRUIT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5783-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5783-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CAULIFLOWER 
    brassica oleracea var. botrytis solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5713
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CAULIFLOWER (UNII: 138LUT2DWV) (CAULIFLOWER - UNII:138LUT2DWV) CAULIFLOWER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5713-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5713-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CHOCOLATE CACAO BEAN 
    theobroma cacao solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5716
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    THEOBROMA CACAO WHOLE (UNII: EB048G1S9J) (THEOBROMA CACAO WHOLE - UNII:EB048G1S9J) THEOBROMA CACAO WHOLE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5716-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5716-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CANTALOUPE MUSKMELON 
    cucumis melo solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5711
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MUSKMELON (UNII: ZV095H5633) (MUSKMELON - UNII:ZV095H5633) MUSKMELON 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5711-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5711-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CARROT 
    daucus carota solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5712
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CARROT (UNII: L56Z1JK48B) (CARROT - UNII:L56Z1JK48B) CARROT 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5712-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5712-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CELERY 
    apium graveolens var. dulce solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5714
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CELERY (UNII: 44IDY6DTKX) (CELERY - UNII:44IDY6DTKX) CELERY 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5714-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5714-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    LETTUCE 
    lactuca sativa solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5728
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LACTUCA SATIVA WHOLE (UNII: C0K52765EZ) (LACTUCA SATIVA WHOLE - UNII:C0K52765EZ) LACTUCA SATIVA WHOLE 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5728-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5728-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    FILBERT HAZELNUT FOOD 
    corylus americana solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5785
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMERICAN HAZELNUT (UNII: IUP4S55D8S) (AMERICAN HAZELNUT - UNII:IUP4S55D8S) AMERICAN HAZELNUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5785-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5785-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    VANILLA 
    vanilla planifolia solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5754
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    VANILLA (UNII: Q74T35078H) (VANILLA - UNII:Q74T35078H) VANILLA 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5754-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5754-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    WHOLE WHEAT 
    triticum aestivum solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5756
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    WHEAT (UNII: 4J2I0SN84Y) (WHEAT - UNII:4J2I0SN84Y) WHEAT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5756-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5756-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    APRICOT 
    prunus armeniaca solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5701
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    APRICOT (UNII: 269CJD5GZ9) (APRICOT - UNII:269CJD5GZ9) APRICOT 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5701-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5701-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    WHOLE GRAIN BARLEY 
    hordeum vulgare solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5703
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BARLEY (UNII: 5PWM7YLI7R) (BARLEY - UNII:5PWM7YLI7R) BARLEY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5703-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5703-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    NAVY BEAN 
    phaseolus vulgaris solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5705
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    KIDNEY BEAN (UNII: M98C8416QO) (KIDNEY BEAN - UNII:M98C8416QO) KIDNEY BEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5705-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5705-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    STRING GREEN BEAN 
    phaseolus vulgaris solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5706
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    STRING BEAN (UNII: N9D69B2Q7Y) (STRING BEAN - UNII:N9D69B2Q7Y) STRING BEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5706-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5706-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CABBAGE 
    brassica oleracea var. capitata solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5710
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CABBAGE (UNII: GW0W1Y9I97) (CABBAGE - UNII:GW0W1Y9I97) CABBAGE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5710-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5710-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CINNAMON 
    cinnamomum verum solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5717
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CINNAMON (UNII: 5S29HWU6QB) (CINNAMON - UNII:5S29HWU6QB) CINNAMON 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5717-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5717-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    COFFEE 
    coffea arabica solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5718
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COFFEA ARABICA SEED, ROASTED (UNII: 9H58JRT35E) (COFFEA ARABICA SEED, ROASTED - UNII:9H58JRT35E) COFFEA ARABICA SEED, ROASTED 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5718-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5718-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    MUSHROOM 
    agaricus campestris solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5730
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FIELD MUSHROOM (UNII: 19988ORO24) (FIELD MUSHROOM - UNII:19988ORO24) FIELD MUSHROOM 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5730-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5730-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    MUSTARD FOOD 
    sinapis alba solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5731
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    WHITE MUSTARD SEED (UNII: 25VR943RPP) (WHITE MUSTARD SEED - UNII:25VR943RPP) WHITE MUSTARD SEED 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5731-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5731-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    BANANA 
    musa acuminata solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5702
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MUSA ACUMINATA FRUIT (UNII: T6ENY6RV6W) (MUSA ACUMINATA FRUIT - UNII:T6ENY6RV6W) MUSA ACUMINATA FRUIT 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5702-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5702-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    COCONUT 
    cocos nucifera solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5784
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COCONUT (UNII: 3RT3536DHY) (COCONUT - UNII:3RT3536DHY) COCONUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5784-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5784-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CORN FOOD 
    zea mays solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5719
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CORN (UNII: 0N8672707O) (CORN - UNII:0N8672707O) CORN 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5719-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5719-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    MALT 
    hordeum vulgare solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5729
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BARLEY (UNII: 5PWM7YLI7R) (BARLEY - UNII:5PWM7YLI7R) BARLEY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5729-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5729-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    BLACK PEPPER 
    piper nigrum solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5740
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLACK PEPPER (UNII: KM66971LVF) (BLACK PEPPER - UNII:KM66971LVF) BLACK PEPPER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5740-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5740-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    LEMON 
    citrus x limon solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5727
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LEMON (UNII: 24RS0A988O) (LEMON - UNII:24RS0A988O) LEMON 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5727-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5727-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    OAT FOOD 
    avena sativa solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5733
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    OAT (UNII: Z6J799EAJK) (OAT - UNII:Z6J799EAJK) OAT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5733-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5733-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    ONION 
    allium cepa solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5735
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ONION (UNII: 492225Q21H) (ONION - UNII:492225Q21H) ONION 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5735-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5735-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CUCUMBER 
    cucumis sativus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5721
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CUCUMBER (UNII: YY7C30VXJT) (CUCUMBER - UNII:YY7C30VXJT) CUCUMBER 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5721-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5721-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    BLUEBERRY 
    vaccinium myrtilloides solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5707
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    VELVETLEAF HUCKLEBERRY (UNII: NXH9EU7QU9) (VELVETLEAF HUCKLEBERRY - UNII:NXH9EU7QU9) VELVETLEAF HUCKLEBERRY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5707-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5707-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    GINGER 
    zingiber officinale solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5723
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GINGER (UNII: C5529G5JPQ) (GINGER - UNII:C5529G5JPQ) GINGER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5723-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5723-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    WHITE SEEDLESS GRAPE 
    vitis vinifera solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5724
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    WINE GRAPE (UNII: 3GOV20705G) (WINE GRAPE - UNII:3GOV20705G) WINE GRAPE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5724-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5724-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    TOMATO 
    solanum lycopersicum solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5753
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TOMATO (UNII: Z4KHF2C175) (TOMATO - UNII:Z4KHF2C175) TOMATO 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5753-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5753-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    GARLIC 
    allium sativum solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5722
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GARLIC (UNII: V1V998DC17) (GARLIC - UNII:V1V998DC17) GARLIC 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5722-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5722-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    SOYBEAN FOOD 
    glycine max solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5749
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SOYBEAN (UNII: L7HT8F1ZOD) (SOYBEAN - UNII:L7HT8F1ZOD) SOYBEAN 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5749-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5749-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    SPINACH 
    spinacia oleracea solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5750
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SPINACH (UNII: 6WO75C6WVB) (SPINACH - UNII:6WO75C6WVB) SPINACH 0.01 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5750-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5750-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    GREEN PEPPER 
    piper nigrum solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5741
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GREEN BELL PEPPER (UNII: 4J4DOU3HEK) (GREEN BELL PEPPER - UNII:4J4DOU3HEK) GREEN BELL PEPPER 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5741-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5741-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    PINEAPPLE 
    ananas comosus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5742
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PINEAPPLE (UNII: 2A88ZO081O) (PINEAPPLE - UNII:2A88ZO081O) PINEAPPLE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5742-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5742-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    STRAWBERRY 
    fragaria x ananassa solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5752
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    STRAWBERRY (UNII: 4J2TY8Y81V) (STRAWBERRY - UNII:4J2TY8Y81V) STRAWBERRY 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5752-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5752-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    YELLOW SUMMER SQUASH 
    cucurbita pepo var. ovifera solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5751
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CUCURBITA PEPO SUBSP. OVIFERA WHOLE (UNII: 2NS91NJI8N) (CUCURBITA PEPO SUBSP. OVIFERA WHOLE - UNII:2NS91NJI8N) CUCURBITA PEPO SUBSP. OVIFERA WHOLE 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5751-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5751-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    BRAZIL NUT 
    bertholletia excelsa solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5782
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BERTHOLLETIA EXCELSA WHOLE (UNII: Z945IQ8X82) (BERTHOLLETIA EXCELSA WHOLE - UNII:Z945IQ8X82) BERTHOLLETIA EXCELSA WHOLE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5782-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5782-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CRANBERRY 
    vaccinium macrocarpon solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5720
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CRANBERRY (UNII: 0MVO31Q3QS) (CRANBERRY - UNII:0MVO31Q3QS) CRANBERRY 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5720-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5720-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    GREEN OLIVE 
    olea europaea solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5734
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GREEN OLIVE (UNII: 6HD2W46UEG) (GREEN OLIVE - UNII:6HD2W46UEG) GREEN OLIVE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5734-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5734-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CHERRY 
    prunus avium solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5715
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SWEET CHERRY (UNII: 93T4562ZI3) (SWEET CHERRY - UNII:93T4562ZI3) SWEET CHERRY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5715-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5715-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    LIMA BEAN 
    phaseolus lunatus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5704
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LIMA BEAN (UNII: 112YH1ZMX2) (LIMA BEAN - UNII:112YH1ZMX2) LIMA BEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5704-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5704-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    HOPS FOOD 
    humulus lupulus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5726
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    HOPS (UNII: 01G73H6H83) (HOPS - UNII:01G73H6H83) HOPS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5726-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5726-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    NUTMEG 
    myristica fragrans solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5732
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MYRISTICA FRAGRANS FRUIT (UNII: GOO22BTU71) (MYRISTICA FRAGRANS FRUIT - UNII:GOO22BTU71) MYRISTICA FRAGRANS FRUIT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5732-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5732-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    PECAN FOOD 
    carya illinoinensis solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5787
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PECAN (UNII: F14P91GB5F) (PECAN - UNII:F14P91GB5F) PECAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5787-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5787-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    SWEET POTATO 
    ipomoea batatas solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5743
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SWEET POTATO (UNII: M9WGG9Z9GK) (SWEET POTATO - UNII:M9WGG9Z9GK) SWEET POTATO 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5743-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5743-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    WHITE POTATO 
    solanum tuberosum solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5744
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POTATO (UNII: CFE1S8DYWD) (POTATO - UNII:CFE1S8DYWD) POTATO 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5744-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5744-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    RED RASPBERRY 
    rubus idaeus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5745
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RASPBERRY (UNII: 4N14V5R27W) (RASPBERRY - UNII:4N14V5R27W) RASPBERRY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5745-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5745-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    ORANGE 
    citrus x sinensis solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5736
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ORANGE (UNII: 5EVU04N5QU) (ORANGE - UNII:5EVU04N5QU) ORANGE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5736-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5736-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    BLACK WALNUT FOOD 
    juglans nigra solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5788
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLACK WALNUT (UNII: 02WM57RXZJ) (BLACK WALNUT - UNII:02WM57RXZJ) BLACK WALNUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5788-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5788-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    WATERMELON 
    citrullus lanatus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5755
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    WATERMELON (UNII: 231473QB6R) (WATERMELON - UNII:231473QB6R) WATERMELON 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PHENOL (UNII: 339NCG44TV)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5755-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5755-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    GRAPEFRUIT 
    citrus x paradisi solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5725
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GRAPEFRUIT (UNII: O82C39RR8C) (GRAPEFRUIT - UNII:O82C39RR8C) GRAPEFRUIT 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5725-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5725-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    PEACH 
    prunus persica solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5738
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEACH (UNII: 3OKE88I3QG) (PEACH - UNII:3OKE88I3QG) PEACH 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5738-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5738-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    PEANUT 
    arachis hypogaea solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5786
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEANUT (UNII: QE1QX6B99R) (PEANUT - UNII:QE1QX6B99R) PEANUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5786-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5786-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:22840-5786-4 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    GREEN ENGLISH PEA 
    pisum sativum solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5737
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PISUM SATIVUM WHOLE (UNII: J21YE3W98E) (PISUM SATIVUM WHOLE - UNII:J21YE3W98E) PISUM SATIVUM WHOLE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5737-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5737-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    PEAR 
    pyrus communis solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5739
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEAR (UNII: 2ZN8DWC0YF) (PEAR - UNII:2ZN8DWC0YF) PEAR 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5739-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5739-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    BEEF 
    bos taurus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5757
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BEEF (UNII: 4PIB2155QP) (BEEF - UNII:4PIB2155QP) BEEF 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5757-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5757-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CHICKEN MEAT 
    gallus gallus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5760
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CHICKEN (UNII: 0X8Q245Y7B) (CHICKEN - UNII:0X8Q245Y7B) CHICKEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5760-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5760-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CHICKEN EGG WHITE 
    gallus gallus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5761
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EGG WHITE (UNII: 3E0I92Z2GR) (EGG WHITE - UNII:3E0I92Z2GR) EGG WHITE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5761-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5761-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CHICKEN EGG YOLK 
    gallus gallus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5763
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EGG YOLK (UNII: 4IPS17B70T) (EGG YOLK - UNII:4IPS17B70T) EGG YOLK 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5763-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5763-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CHICKEN EGG WHOLE 
    gallus gallus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5762
    Route of Administration PERCUTANEOUS, INTRADERMAL, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EGG (UNII: 291P45F896) (EGG - UNII:291P45F896) EGG 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5762-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5762-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    LAMB 
    ovis aries solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5758
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LAMB (UNII: FOF26T73HA) (LAMB - UNII:FOF26T73HA) LAMB 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5758-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5758-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    PORK 
    sus scrofa solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5759
    Route of Administration PERCUTANEOUS, INTRADERMAL, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PORK (UNII: O138UB266J) (PORK - UNII:O138UB266J) PORK 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5759-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5759-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    TURKEY MEAT 
    meleagris gallopavo solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5764
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TURKEY (UNII: 8E9NT44R8I) (TURKEY - UNII:8E9NT44R8I) TURKEY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5764-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5764-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    COW MILK 
    bos taurus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5765
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SKIM MILK (UNII: 6A001Y4M5A) (SKIM MILK - UNII:6A001Y4M5A) SKIM MILK 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5765-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5765-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    BLACK BASS 
    centropristis striata solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5766
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLACK SEA BASS (UNII: 0YJW8KYT51) (BLACK SEA BASS - UNII:0YJW8KYT51) BLACK SEA BASS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5766-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5766-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CATFISH 
    ictalurus punctatus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5767
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CHANNEL CATFISH (UNII: FIX499R7DR) (CHANNEL CATFISH - UNII:FIX499R7DR) CHANNEL CATFISH 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5767-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5767-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CLAM 
    mercenaria mercenaria solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5768
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    NORTHERN QUAHOG (UNII: D6G49OV9IM) (NORTHERN QUAHOG - UNII:D6G49OV9IM) NORTHERN QUAHOG 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5768-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5768-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    ATLANTIC COD 
    gadus morhua solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5769
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ATLANTIC COD (UNII: RPX7J99EXW) (ATLANTIC COD - UNII:RPX7J99EXW) ATLANTIC COD 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5769-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5769-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    CRAB 
    callinectes sapidus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5770
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLUE CRAB (UNII: 8J18RFO4A8) (BLUE CRAB - UNII:8J18RFO4A8) BLUE CRAB 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5770-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5770-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    FISH MIX 
    gadus morhua, paralichthys lethostigma, hippoglossus hippoglossus, scomber scombrus and thunnus albacares solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-9700
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SOUTHERN FLOUNDER (UNII: F8PTG78KRB) (SOUTHERN FLOUNDER - UNII:F8PTG78KRB) SOUTHERN FLOUNDER 0.01 g  in 1 mL
    ATLANTIC MACKEREL (UNII: HO615U86UJ) (ATLANTIC MACKEREL - UNII:HO615U86UJ) ATLANTIC MACKEREL 0.01 g  in 1 mL
    YELLOWFIN TUNA (UNII: 12ZC3K09X7) (YELLOWFIN TUNA - UNII:12ZC3K09X7) YELLOWFIN TUNA 0.01 g  in 1 mL
    ATLANTIC COD (UNII: RPX7J99EXW) (ATLANTIC COD - UNII:RPX7J99EXW) ATLANTIC COD 0.01 g  in 1 mL
    ATLANTIC HALIBUT (UNII: 7E34E106BO) (ATLANTIC HALIBUT - UNII:7E34E106BO) ATLANTIC HALIBUT 0.01 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-9700-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-9700-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    SHELLFISH MIX 
    mercenaria mercenaria, callinectes sapidus, crassostrea virginica, placopecten magellanicus and farfantepenaeus aztecus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-9701
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLUE CRAB (UNII: 8J18RFO4A8) (BLUE CRAB - UNII:8J18RFO4A8) BLUE CRAB 0.01 g  in 1 mL
    NORTHERN QUAHOG (UNII: D6G49OV9IM) (NORTHERN QUAHOG - UNII:D6G49OV9IM) NORTHERN QUAHOG 0.01 g  in 1 mL
    EASTERN OYSTER (UNII: 0I77C68AWS) (EASTERN OYSTER - UNII:0I77C68AWS) EASTERN OYSTER 0.01 g  in 1 mL
    SEA SCALLOP (UNII: BY65V9YV1I) (SEA SCALLOP - UNII:BY65V9YV1I) SEA SCALLOP 0.01 g  in 1 mL
    NORTHERN BROWN SHRIMP (UNII: TJH4LL437H) (NORTHERN BROWN SHRIMP - UNII:TJH4LL437H) NORTHERN BROWN SHRIMP 0.01 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-9701-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-9701-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    FLOUNDER 
    paralichthys lethostigma solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5771
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SOUTHERN FLOUNDER (UNII: F8PTG78KRB) (SOUTHERN FLOUNDER - UNII:F8PTG78KRB) SOUTHERN FLOUNDER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5771-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5771-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    MAINE LOBSTER 
    homarus americanus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5772
    Route of Administration PERCUTANEOUS, INTRADERMAL, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMERICAN LOBSTER (UNII: 6T362S6JF6) (AMERICAN LOBSTER - UNII:6T362S6JF6) AMERICAN LOBSTER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5772-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5772-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    MACKEREL 
    scomber scombrus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5773
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ATLANTIC MACKEREL (UNII: HO615U86UJ) (ATLANTIC MACKEREL - UNII:HO615U86UJ) ATLANTIC MACKEREL 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5773-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5773-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    OYSTER 
    crassostrea virginica solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5774
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EASTERN OYSTER (UNII: 0I77C68AWS) (EASTERN OYSTER - UNII:0I77C68AWS) EASTERN OYSTER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5774-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5774-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    OCEAN PERCH 
    sebastes alutus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5775
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PACIFIC OCEAN PERCH (UNII: 81369ZC3RW) (PACIFIC OCEAN PERCH - UNII:81369ZC3RW) PACIFIC OCEAN PERCH 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5775-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5775-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    SALMON 
    salmo salar solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5776
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ATLANTIC SALMON (UNII: 7062I37LB3) (ATLANTIC SALMON - UNII:7062I37LB3) ATLANTIC SALMON 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5776-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5776-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    SCALLOPS 
    placopecten magellanicus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5777
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SEA SCALLOP (UNII: BY65V9YV1I) (SEA SCALLOP - UNII:BY65V9YV1I) SEA SCALLOP 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5777-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5777-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    SHRIMP 
    farfantepenaeus aztecus solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5778
    Route of Administration PERCUTANEOUS, INTRADERMAL, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    NORTHERN BROWN SHRIMP (UNII: TJH4LL437H) (NORTHERN BROWN SHRIMP - UNII:TJH4LL437H) NORTHERN BROWN SHRIMP 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5778-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5778-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    LAKE TROUT 
    oncorhynchus mykiss solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5779
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RAINBOW TROUT (UNII: P4M52SZ8L6) (RAINBOW TROUT - UNII:P4M52SZ8L6) RAINBOW TROUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5779-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5779-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    TUNA 
    thunnus albacares solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5780
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    YELLOWFIN TUNA (UNII: 12ZC3K09X7) (YELLOWFIN TUNA - UNII:12ZC3K09X7) YELLOWFIN TUNA 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5780-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5780-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    ALMOND FOOD 
    prunus dulcis solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5781
    Route of Administration INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALMOND (UNII: 3Z252A2K9G) (ALMOND - UNII:3Z252A2K9G) ALMOND 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5781-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:22840-5781-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    APPLE 
    malus pumila solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5700
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    APPLE (UNII: B423VGH5S9) (APPLE - UNII:B423VGH5S9) APPLE 0.025 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5700-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5700-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    ENGLISH WALNUT 
    juglans regia solution
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:22840-5789
    Route of Administration SUBCUTANEOUS, INTRADERMAL, PERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ENGLISH WALNUT (UNII: 1V3SHR7QB7) (ENGLISH WALNUT - UNII:1V3SHR7QB7) ENGLISH WALNUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    PHENOL (UNII: 339NCG44TV)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:22840-5789-5 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    2 NDC:22840-5789-2 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101833 09/15/1981
    Labeler - Greer Laboratories, Inc. (024671414)
    Registrant - Greer Laboratories, Inc. (024671414)
    Establishment
    Name Address ID/FEI Business Operations
    Greer Laboratories, Inc. 024671414 manufacture(22840-1100, 22840-1101, 22840-1102, 22840-1103, 22840-1105, 22840-1106, 22840-1107, 22840-1108, 22840-1110, 22840-1111, 22840-1112, 22840-1113, 22840-1116, 22840-1117, 22840-1118, 22840-1119, 22840-1121, 22840-1122, 22840-1123, 22840-1125, 22840-1126, 22840-1127, 22840-1128, 22840-1129, 22840-1130, 22840-1131, 22840-1133, 22840-1134, 22840-1135, 22840-1136, 22840-1138, 22840-1139, 22840-1140, 22840-1141, 22840-1142, 22840-1144, 22840-1145, 22840-1146, 22840-1147, 22840-1149, 22840-1150, 22840-1151, 22840-1153, 22840-1154, 22840-1155, 22840-1157, 22840-1159, 22840-1160, 22840-1162, 22840-1163, 22840-1164, 22840-1167, 22840-1168, 22840-1169, 22840-1170, 22840-1171, 22840-1173, 22840-1174, 22840-1175, 22840-1176, 22840-1537, 22840-1538, 22840-5100, 22840-5101, 22840-5102, 22840-5103, 22840-5104, 22840-5105, 22840-5106, 22840-5107, 22840-5108, 22840-5109, 22840-5110, 22840-5111, 22840-5112, 22840-5113, 22840-5114, 22840-5115, 22840-5517, 22840-9100, 22840-9101, 22840-9102, 22840-9103, 22840-9104, 22840-9105, 22840-9107)
    Close